Social media

In just two days Andrew Roche, Senior Director of Scientific Affairs, will present at the Biomarkers & Precision Medicine conference. His session, “Key considerations for high-quality data generation in global clinical ...

Discover how ICON helped a sponsor overcome recruitment challenges in a competitive, technically complex environment leveraging targeted site selection and operational precision to exceed enrolment goals and safeguard co...

The therapeutic landscape for obesity is changing rapidly. Endpoints focused only on weight loss are no longer enough. Regulators now expect measures that capture the entire patient experience. Join ICON experts on Oct...

The therapeutic landscape for obesity is changing rapidly. Endpoints focused only on weight loss are no longer enough. Regulators now expect measures that capture the entire patient experience. Join ICON experts on Oct...

We are pleased to share that ICON has been recognised for the second consecutive year by the Mamá Godín initiative in Mexico. This recognition reflects our commitment to supporting working parents and caregivers through ...

Discover the value of strategic early engagement during Stacey Flattery Vice President, General Partner, speaker session on Wednesday, 15 October at 11:30am at #OCTNewEngland2025. Learn how to optimize clinical outsourc...

Discover the value of strategic early engagement during Stacey Flattery Vice President, General Partner, speaker session on Wednesday, 15 October at 11:30am at #OCTNewEngland2025. Learn how to optimize clinical outsourc...

Ensuring that a cardiovascular outcomes trial is conducted consistently across all trial sites, particularly international ones, helps minimise confounding variables and supports the validity of the trial’s findings. I...

Ensuring that a cardiovascular outcomes trial is conducted consistently across all trial sites, particularly international ones, helps minimise confounding variables and supports the validity of the trial’s findings. ICO...

As clinical trials grow more complex, programming strategies must evolve. R, an open-source programming language for statistical computing, is enabling greater efficiency, higher quality outputs and faster data driven de...

As clinical trials grow more complex, programming strategies must evolve. R, an open-source programming language for statistical computing, is enabling greater efficiency, higher quality outputs and faster data driven de...

As global pressures reshape the pharmaceutical and biotech landscape, sponsors are re-evaluating their outsourcing strategies. In this article, Maria DiPietro shares insights from ICON’s recent survey of industry stakeho...